DENOSUMAB (Prolia®)
Clinical Indication
Osteoporosis
Date of classification
May 2014
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.